Epoprostenol
Back to searchMolecule Structure
Scientific Name
Epoprostenol
Description of the Drug
Epoprostenol is a vasodilator and platelet aggregation inhibitor used for the management of primary pulmonary hypertension and pulmonary hypertension in patients with heart failure.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-02-07 from
http://www.drugbank.ca/drugs/DB01240
http://www.drugbank.ca/drugs/DB01240
Brand Name(s)
Not Available
Company Owner(s)
Actelion Pharmaceuticals Us Inc, Glaxosmithkline Llc, Teva Pharmaceuticals Usa, Sun Pharmaceutical Industries Ltd
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Prostanoid IP receptor | SINGLE PROTEIN | AGONIST | CHEMBL1995 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL8041 | |||||
| Human Metabolome Database | HMDB0001335 | |||||
| DrugBank | DB01240 | |||||
| PubChem: Thomson Pharma | 14900947 | |||||
| PubChem | 5282411 | |||||
| Nikkaji | J17.550A | |||||
| EPA CompTox Dashboard | DTXSID5022988 | |||||
| LipidMaps | LMFA03010087 | |||||
| DrugCentral | 1034 | |||||
| Metabolights | MTBLC15552 | |||||
| Brenda | 47566 | 204317 | 29197 | 6018 | 3844 | 44649 |
| Guide to Pharmacology | 1915 | |||||
| GSRS | 6ed7532f-7e36-4ff6-902d-c57e042d5a76 | |||||
| rxnorm | FLOLAN | EPOPROSTENOL | EPOPROSTENOL SODIUM | |||
| ChEBI | 15552 | |||||
| ZINC | ZINC000003813078 |
